Actavis set for $20 billion corporate-bond sale
March 02, 2015 at 05:13 AM EST
Pharmaceutical company Actavis, which the cash to help pay for its $66 billion purchase of health-care firm Allergan, is headed for a deal that would rank as the second-largest corporate bond ever.
